Accreditation

New antibiotic-resistant organism elicits CDC recommendations

Ambulatory Quality and Compliance Insider, July 1, 2009

This is an excerpt from a member only article. To read the article in its entirety, please login.

Although much of the focus of multidrug-resistant organisms has been on methicillin-resistant Staphylococcus aureus (MRSA), a relatively new and potentially more dangerous infectious disease has begun to draw attention from infection control experts.
Carbapenem-resistant or carbapenemase-producing Enterobacteriaceae (CRE) have recently emerged as the most common gram-negative bacteria and a challenge for providers worldwide.
More specifically, according to the March 20 Morbidity and Mortality Weekly Report (MMWR), carbapenem-¬resistant Klebsiella pneumoniae (CRKP) is a species of CRE associated with high morbidity and mortality, prolonged length of stay, and increased cost. Physicians in the United States have come across this bacterium more frequently, particularly in New York City and New Jersey.

This is an excerpt from a member only article. To read the article in its entirety, please login.

Most Popular

Related Articles